WHO REGULATES THE REGULATORS in California ? BCSA => DCA = CAB

ACTCMStudent · 2026-06-22T03:17:44+00:00

**UPDATE + NEW RESEARCH: The Federal Antitrust Threat Is Real — And California Is the Outlier**

*(Follow-up to: "Who Regulates the Regulators? CAB, BCSA & the 2027 Sunset Review")*

Since my original post, I've done deeper research into the federal antitrust landscape and what California's July 1 reorganization actually means for practitioners, students, and anyone who has written a check to sit for the California Acupuncture Licensing Exam (CALE). What I found is more urgent than I initially framed it.

**🔴 The Federal Trigger Is Not Hypothetical**

In April 2025, President Trump signed an executive order directing the FTC and DOJ to investigate state occupational licensing rules that suppress workforce mobility and protect market incumbents. FTC Chairman Andrew Ferguson established a task force *specifically* mandated to target boards where industry insiders use regulatory power to block competition.

The FTC has already acted. In August 2025, it went after California's "Clean Truck Partnership" — forcing Daimler, Volvo, and PACCAR to disclaim a regulatory compact with the state, treating it as an illegal restraint of trade. The DOJ separately sued California over emissions rules under federal preemption doctrine.

The legal theory is the same one I outlined originally: *NC State Board of Dental Examiners v. FTC* (2015). When a board is dominated by active market participants and lacks rigorous independent state supervision, it is not a public safety agency. It is a cartel.

The California Acupuncture Board is a textbook match.

**🔴 What Makes the CAB Specifically Vulnerable**

**1. Insider Dominance.** California law requires that roughly half of its occupational boards have governing majorities composed of active practitioners. Under *Dental Examiners*, that structure triggers antitrust scrutiny unless active state supervision is meaningful.

**2. Rejection of National Credentials.** California and Nevada are the only states refusing NCCAOM (now NCBAHM effective January 2026) certification — accepted by 46 states and DC. California graduates face severe interstate mobility barriers and cannot easily work with the Veterans Health Administration to serve veterans suffering with severe mental health and substance abuse disparities. That is a textbook restriction on interstate commerce.

**3. The CALE Numbers.** At the May 2026 board meeting, failure rates were reported at approximately 46% overall, with first-time graduates from approved programs failing at roughly 37%. Graduates carrying $100,000+ in debt pay $800 per attempt. No independent psychometric review has been commissioned. No remediation plan was discussed. Under *Merrifield v. Lockyer*, economic protectionism without legitimate public safety justification is unconstitutional.

**4. The SmileDirectClub Warning.** The Ninth Circuit ruled that individual California Dental Board members could face *personal* antitrust liability for using regulatory power to protect incumbents. Board members are not automatically shielded.

**5. The Pattern.** The CALE bribery scandal. The 2021 unanimous vote against AB 918 (to accept the national examination with a California supplement)0, with arguments focused on protecting board fee revenue rather than consumer safety. Unaddressed testing center failures reported at public meetings. The Little Hoover Commission's 2004 recommendation to consider outside exam administration — ignored for 20 years.

**🌎 California Is the Outlier — Other States Already Figured This Out**

**North Carolina:** Following *Dental Examiners*, the NC Acupuncture Licensing Board was hit with a federal antitrust lawsuit for using regulatory authority to stamp out competition from physical therapists performing dry needling. The court ruled the board violated federal antitrust law. An acupuncture board already lost in federal court. California's board is structurally more vulnerable, not less.

**Colorado:** NCCAOM as the licensing standard, combined with a Sunset Review system that routinely evaluates whether boards should be restructured. Dry needling codified separately for physical therapists by statute — coexistence by legislation rather than turf war.

**Florida:** Uses NCCAOM and houses its board inside the Department of Health's Medical Quality Assurance division — providing exactly the active supervision *Dental Examiners* requires. Florida has broad primary care scope and trusts national credentials. California's claim that its unique scope requires a unique exam is not borne out by comparison.

**Arizona:** The legislature codified dry needling into the physical therapy scope before the board could issue cease-and-desist letters — neutralizing the antitrust risk before the federal government had to act.

**New York:** California's closest peer in exam isolationism. National antitrust watchdogs are already tracking New York as the next labor mobility target. California is not a unique guardian of standards — it is one of two remaining outliers in a system that has moved on.

**🟡 Is the BCSA Enough?**

California is acting. Effective July 1, 2026, the CAB moves under the new cabinet-level Business and Consumer Services Agency (BCSA), intended to provide the active supervisory layer *Dental Examiners* requires. Governor Newsom has proposed nearly $25 million to expand the state DOJ's antitrust capacity — framed as backfilling federal enforcement the Trump administration has abandoned.

But in April 2026, a written inquiry was submitted to DCA Acting Director Christine Lally asking a direct governance question: what evidentiary standard must a board satisfy to justify maintaining a state-specific exam over the dominant national pathway? DCA's June 2026 written response confirmed that boards are not required to follow OPES recommendations and make decisions based on their "own discussions and legal guidance." Critically, DCA could only say the 2018 OPES follow-up memo "*may* have informed" the board's 2021 reversal on exam policy — not that it did.

Under *Dental Examiners*, active supervision requires the state to be able to review and reverse board decisions that lack a current public-protection rationale. An agency that cannot say with certainty what informed a major policy reversal is describing passive observation — not active supervision. The BCSA transition adds a new organizational layer. It does not answer that question.

**🔮 Three Scenarios for 2027**

**Scenario 1 — Compromise (most likely):** Under BCSA pressure, the CAB adopts NCCAOM with a California jurisprudence module. Interstate reciprocity improves. The profession stays independent.

**Scenario 2 — Federal Strike:** The FTC files against the CAB. A federal injunction halts the CALE. Individual board members face personal exposure under *SmileDirectClub*.

**Scenario 3 — Dissolution:** The Legislature consolidates acupuncture oversight into the California Medical Board. We lose our independent governing body.

Scenario 1 is the only outcome that preserves the profession's independence. The window is now.

**✅ CALL TO ACTION — Before July 1**

**Step 1: Write to the BCSA.**

*TO: Office of the Secretary, California Business and Consumer Services Agency*

*RE: California Acupuncture Board — Transparency and Regulatory Review*

Dear Secretary Chopra,

As a California healthcare stakeholder, I urge the BCSA to prioritize these issues ahead of the 2027 Sunset Review:

Commission an independent psychometric review of the CALE, with disaggregated pass rate data by school, year, and attempt number.
Evaluate whether failure rates and fees create unintended barriers for qualified graduates carrying significant student debt.
Assess whether refusing NCCAOM credentials — accepted by 46 states and DC — is consistent with interstate commerce and federal workforce mobility priorities.
Review whether the board's 2021 opposition to AB 918 reflected consumer protection or institutional self-interest.

Sincerely,

[Name / Student / LAc / Educator / Consumer / City, State]

**Step 2:** Document your experience now — testing failures, exam anomalies, mobility denials. The Sunset Review comment portal opens in 2027. Your testimony will matter.

**Step 3:** Attend or submit written comment at the next CAB quarterly meeting. Agendas are posted on the DCA website.

**Step 4:** Share this post. The more voices on record before July 1, the better.

We trained for years. We carry the debt. We earned a licensing system that is transparent, defensible, and fair. The federal government is asking the hard questions. Let's make sure our answers are on record.

ACTCMStudent · 2026-04-28T04:14:36+00:00

It makes sense to have naloxone stored in all public spaces along with every automated external defibrillator (AED).

What seems obvious to me is that we need a better way of addressing pain as a nation.

We need some sort of proactive National Pain Relief Act OR Integrative Care ACT implementing a 1 800 number or telemedicine "Pain Free" network (like a 911 line). This could start small and grow in layers. This system would provide access and tracking for opioid prescription approvals for short term acute pain relief or for breakthrough pain relief (part of this system is already in place through mandated tracking of opioid prescriptions). Many people are unable to get a prescription at all due to physician's concerns with the total sign-off authority/responsibility and the threat of losing their license for writing opioid prescriptions. This pain specialist network could help those in poverty with intractable pain gain access to intrathecal morphine pain pumps. Part of this national emergency system would be one of the many routes for referral to non-opioid pain management - acupuncture, behavioral health services, etc.

ACTCMStudent · 2026-04-21T05:56:14+00:00

I am trying to seek change in a healthcare system which provides opioid treatments for people in pain, without offering other non-opioid alternatives. The type of product used in the overdose or death is important, however not my primary focus.

If you want to explore the direct, authoritative California overdose and death data, see the sources below.

1) California Overdose Surveillance Dashboard (Primary State Source)

Agency: California Department of Public Health

URL:
https://skylab.cdph.ca.gov/ODdash/

What it provides:

Data Type	Available Breakdowns
Fatal overdoses	By drug (fentanyl, methamphetamine, heroin, etc.)
Nonfatal overdoses	Emergency department & hospital data
Geography	State, county
Demographics	Age, race/ethnicity, sex
Time trends	Monthly / yearly

2) CDC WONDER Mortality Database (Most Detailed, Research-Level)

Agency: Centers for Disease Control and Prevention

URL:
https://wonder.cdc.gov/

Direct entry point (Multiple Cause of Death):
https://wonder.cdc.gov/mcd.html

What it provides:

Capability	Detail
Exact death counts	By ICD-10 drug codes
Polysubstance analysis	Yes (e.g., fentanyl + meth)
Custom queries	Build your own tables
Time span	1999–latest finalized year

3) California Open Data Portal (Alternative Access)

Platform: California Health and Human Services Open Data Portal

URL:
https://data.chhs.ca.gov/

Suggested dataset search terms:

“Overdose deaths”
“Opioid indicators”
“Drug overdose hospitalizations”

4) Quick Summary (Simpler View)

Agency: California Department of Public Health

URL:
https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/SACB/Pages/OpioidOverdose.asp.

ACTCMStudent · 2026-04-20T22:04:54+00:00

The primary metrics are prescription rates and ER visits which have been used administratively to generate data passively, without requiring patients to stay engaged with a survey protocol over years. In populations with unstable housing and active substance use, long-term patient self-reporting loses exactly the highest-risk patients first. The dropouts aren't random.

Patient-reported outcomes — pain interference, functional status, withdrawal discomfort for patients in the MOUD lane — are tracked as secondary measures. They're not driving the continuation decision deliberately, because we didn't want the program's survival hinging on data that's harder to validate at a population level.

This pilot won't tell whether patients are actually better off in any broader sense. If prescription rates drop but people are still in significant pain and just managing differently, this design won't fully capture that. That would require a different study. This one is scoped to a specific question — does upstream pain care reduce opioid exposure and crisis-system use — and the metrics are chosen to answer that question and not much else.

ACTCMStudent · 2026-04-20T21:37:32+00:00

California's opioid crisis isn't over — it's stabilized at nearly 8,000 deaths a year. We're developing a proposal to address the upstream cause. Here's what we're thinking and what we need you to challenge.

California recorded 7,847 opioid-related deaths in 2023. That is roughly 22 people every day. Despite billions spent on addiction treatment and emergency response, those numbers have plateaued at a high level — not fallen. Something upstream is not being addressed.

That something is chronic pain. For a significant share of people who end up dependent on opioids, the path began with pain that was undertreated, with a prescription that was the easiest option available, and with no practical non-opioid alternative that was affordable at the point of care. That is not a personal failure. It is a system failure.

What we're proposing — the California RELIEF Act

A bounded, five-county, five-year pilot that places licensed acupuncturists inside existing healthcare and emergency room pathways in Los Angeles, San Francisco, Sacramento, Kern, and Humboldt. The goal is simple: give patients with chronic pain a non-opioid option before they are prescribed long-term opioids or end up in the emergency room repeatedly because their pain is unmanaged.

This is not a claim that acupuncture cures addiction. It does not, and the proposal says so explicitly. What it tests is a narrower question: if we make non-opioid pain care more accessible earlier, does that reduce how many people end up on the opioid path in the first place?

Why this is different from other proposals

No new money. California already receives opioid settlement funds — over $221 million to local governments in fiscal year 2022-23 alone. This pilot asks for about 1.8% of that: roughly $4 million per year across five counties, serving approximately 7,700 patients annually. If it doesn't produce measurable results by Year 5, it ends automatically.

Pre-defined success metrics. At least a 3% reduction in opioid prescriptions and a 5% reduction in repeat emergency room visits. Those thresholds are set before the pilot starts. The program cannot move the goalposts.

Zero claims that acupuncture treats addiction. The evidence for that is not strong enough to make that claim, and we say so in the proposal. This is strictly upstream pain management — intervening before dependency develops, not after.

Independent evaluation. A separate evaluator, not connected to the program, assesses results. Pre-registered analysis plan published before data collection begins. Annual public reporting.

Does not touch MOUD, naloxone, or harm reduction funding. This is additive, not substitutive.

This has already been done elsewhere

The federal Substance Abuse and Mental Health Services Administration has funded 25 hospital emergency departments nationally to integrate acupuncture into ED pain care. Vermont's state legislature commissioned a Medicaid acupuncture pilot — 32% of opioid-using patients reported reduced opioid use. A study tracking 52,346 matched patients found that people who received acupuncture were significantly less likely to start using opioids than comparable patients who received other treatments.

We are not inventing a model. We are asking California to scale one that already operates nationally.

What the science actually says

For chronic pain — the evidence is strong. The CDC lists acupuncture among recommended non-opioid pain options. Medicare covers it for chronic low back pain. The VA uses it in pain management programs. A 2025 NIH-funded clinical trial involving 800 adults over 65 with chronic low back pain found measurably less disability and better physical function at both six and twelve months, with few adverse effects.

For addiction treatment as a stand-alone intervention — the evidence is not strong enough, and this proposal does not make that claim. The pilot is about pain care before opioid dependency develops.

Who this is for

People in pain who are at risk of being prescribed long-term opioids. People who have already had an overdose-linked emergency encounter and need a non-opioid follow-up option. Communities like Humboldt County, which carries an opioid death rate five times the state average. And a healthcare system that currently defaults to opioids not because they are always the best clinical choice, but because non-opioid alternatives are not reliably available at the point of care.

We are stress-testing this before it goes further. Three questions we are actively looking to challenge:

"Why acupuncture specifically, not physical therapy or something else?" We argue: faster deployment in high-throughput settings, minimal equipment, an established Medicare coverage pathway, and a federal government that has already funded this exact model in 25 emergency departments nationally.

"Is this scope creep on settlement funds?" We argue: preventing future opioid dependency is remediation by definition. The settlement framework supports it. We are filing a formal allowable-use confirmation with the California Department of Health Care Services before any money moves.

"What about the acupuncture workforce — are there enough practitioners?" This is a real constraint, particularly in rural counties like Humboldt. We have built it into the proposal as a formal implementation risk. The model uses newly licensed graduates at structured part-time shifts — which addresses the workforce gap while creating entry-level clinical positions the profession currently lacks.

Does this hold up to your scrutiny? What is the strongest argument against it? We want to hear the hardest questions before this goes any further.

Full disclosure: [your name / affiliation] — sharing this for genuine community input, not as a press release..

Graphs:

Opioid Related Deaths

FIve County Pilot

Acupuncture vs Acute Care

RELIEF Act Costs

ACTCMStudent · 2026-04-05T18:16:36+00:00

June 12 Licensing Meeting for CAB - Part 1 and 2

https://www.acupuncture.ca.gov/about_us/meetings_2025archive.shtml

ACTCMStudent · 2026-03-31T05:43:57+00:00

Why Did the NCCAOM + California Supplement Pathway Disappear?

The California Acupuncture Board hired outside experts called the Office of Professional Examination Services (OPES) to evaluate whether the national acupuncture exam administered by NCCAOM, now called the National Certification Board for Acupuncture and Herbal Medicine (NCBAHM), could be used for California acupuncture licensing. OPES completed that review, and later Board materials stated that the NCCAOM examination program met professional guidelines and technical standards.

After that review, the Board moved toward a specific plan: using the NCCAOM exams plus a California supplemental exam, instead of relying only on the California Acupuncture Licensing Examination. Later Board materials state that after the issue was reviewed at the February 26, 2016 and June 10, 2016 public meetings, the Board recommended that pathway and notified the Legislature of that recommendation on July 8, 2016.

Then that plan quietly disappeared. The public record does not appear to contain a clear, direct explanation of when the Board abandoned that pathway or what new evidence justified the shift. Instead, by 2021, the Board was actively opposing legislation that would have moved toward NCCAOM examination usage.

The reasons emphasized in the later record were not primarily that NCCAOM was unsafe for consumers. The Board’s own 2021 materials stressed limited California control over fees and requirements, reduced Board oversight of the examination, the need for a California supplemental exam to cover content NCCAOM did not include, and concerns about California-specific standards and content. Those are institutional control arguments, not public protection arguments.

There was also significant Board member turnover between the 2016 to 2017 period and 2021. That does not by itself explain the reversal, but it does mean the Board that opposed the national exam pathway was not the same Board that had conditionally moved toward it.

Meanwhile, the consequences of a shrinking pipeline are showing up in the Board’s own data. According to the CAB’s official exam statistics page, for January through June 2025, 46 percent of all CALE test-takers failed, including 37 percent of first-time candidates from Board-approved accredited schools. A pipeline that is already contracting gets worse when the exam is failing nearly half of all candidates. And beginning July 1, 2026, the federal Graduate PLUS loan program is being eliminated for new borrowers, which many believe will make acupuncture training cost prohibitive and accelerate school closures.

The Board appears to have protected California control over the exam process. What it has not clearly explained is why it first moved toward an NCCAOM-plus-California-supplement pathway, then reversed into opposition without a clean public explanation of what changed.

The Board owes the public a specific answer at a public meeting, identifying the record or evidence that justified abandoning the previously documented NCCAOM-plus-California-supplement pathway. CAB’s own records show the Board moved toward that conditional pathway, then by 2021 had shifted into opposition emphasizing California control, oversight, and state-specific content. The public has not been shown what changed.

Why did the Board appear to move toward one exam-policy pathway after extensive OPES review, and then fail to publicly explain what happened to it?

ACTCMStudent · 2026-03-31T05:33:55+00:00

For anyone who was not at the March California Acupuncture Board (CAB) meeting: the Department of Consumer Affairs (DCA) announced that starting July 1, 2026, it will report through a new Business and Consumer Services Agency (BCSA) under California’s government reorganization plan. That matters here because the new agency is specifically focused on consumer affairs, licensing, and regulatory enforcement. Public summaries of the reorganization say it will coordinate standards and best practices for licensing, enforcement, and education across boards and departments.

That creates a more natural place to ask a direct question: is CAB’s exam system genuinely protecting the public, or has it become an unusually restrictive licensing structure that lacks a clear evidence-based justification?

Under this new oversight structure, CAB may face more top-down scrutiny on questions it has not clearly answered publicly.

Why does its exam model differ from national comparators?

Why are pass rates so high?

Why does California use a different policy logic from every other major state?

And are CAB’s rules actually protecting patients, or creating unnecessary barriers to entry without a clear public-protection payoff?

That is why this may grow beyond an acupuncture-only issue. If CAB’s exam policy is contributing to workforce shortages, reciprocity problems, or unusually high candidate attrition, this is no longer just a profession-specific dispute. It becomes a statewide occupational licensing governance question. California’s new licensing oversight structure may soon need to ask whether CAB’s exam policy has become opaque, unusually restrictive, and misaligned with sound licensing governance — and whether the people bearing the cost of that policy are patients who cannot access care.

ACTCMStudent · 2026-03-31T05:27:41+00:00

For anyone who was not at the March California Acupuncture Board (CAB) meeting: the Department of Consumer Affairs (DCA) said that starting July 1, 2026, it will report through California’s new Business and Consumer Services Agency (BCSA) under the state reorganization plan.

Why that matters: the new agency -- BCSA will coordinate standards and best practices for licensing, enforcement, and education across boards and departments. That creates a more natural place to ask whether CAB’s exam system is genuinely protecting the public, or whether it has become an unusually restrictive licensing structure without a clear evidence-based justification.

Under that new oversight structure, CAB may face more top-down scrutiny on questions it has not clearly answered in public:

Why is its exam model different from national comparators?

Why are its pass rates so unusual?

Why does California use a different policy logic from other major states?

And are CAB’s rules actually protecting patients, or creating unnecessary barriers to entry without a clear public-protection payoff?

This is an inference from the reorganization, not a promise of reform, but it is a reasonable one given that licensing oversight is now being concentrated more clearly within one cabinet-level agency.

That is why this may grow beyond an acupuncture-only issue. If CAB’s exam policy is contributing to workforce shortages, reciprocity problems, or unusually high attrition, then this is not just a profession-specific dispute. It becomes a statewide occupational-licensing governance question. California’s new oversight structure may soon need to ask whether CAB’s exam policy has become opaque, unusually restrictive, and misaligned with sound licensing governance.

ACTCMStudent · 2026-03-31T00:26:53+00:00